TD Waterhouse Canada’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.96K | Hold |
6,900
| – | – | ﹤0.01% | 1478 |
|
|
2025
Q1 | $6.43K | Hold |
6,900
| – | – | ﹤0.01% | 1488 |
|
|
2024
Q4 | $8.77K | Hold |
6,900
| – | – | ﹤0.01% | 1440 |
|
|
2024
Q3 | $13.7K | Hold |
6,900
| – | – | ﹤0.01% | 1300 |
|
|
2024
Q2 | $13.7K | Hold |
6,900
| – | – | ﹤0.01% | 1300 |
|
|
2024
Q1 | $16.6K | Hold |
6,900
| – | – | ﹤0.01% | 1261 |
|
|
2023
Q4 | $8.21K | Hold |
6,900
| – | – | ﹤0.01% | 1292 |
|
|
2023
Q3 | $8K | Hold |
6,900
| – | – | ﹤0.01% | 1280 |
|
|
2023
Q2 | $8K | Hold |
6,900
| – | – | ﹤0.01% | 1294 |
|
|
2023
Q1 | $4.62K | Hold |
6,900
| – | – | ﹤0.01% | 1386 |
|
|
2022
Q4 | $4.97K | Hold |
6,900
| – | – | ﹤0.01% | 1351 |
|
|
2022
Q3 | $9.45K | Hold |
6,900
| – | – | ﹤0.01% | 1242 |
|
|
2022
Q2 | $11.8K | Hold |
6,900
| – | – | ﹤0.01% | 1216 |
|
|
2022
Q1 | $12.5K | Hold |
6,900
| – | – | ﹤0.01% | 1270 |
|
|
2021
Q4 | $15.8K | Buy |
+6,900
| New | +$15.8K | ﹤0.01% | 1249 |
|